Suggested Posts

Nothing Found! Ready to publish your first post? Get started here.

Follow

Twitter 5K Linkedin 100 Tiktok 1

Popular

Turmoil at the CDC Means that Vaccine Access Is Already Being Impacted in a Real Way

Novo’s Latest Pharm-to-Table Deals Show How the Trend Is Evolving into an Ecosystem

People Are Getting Real Nervous About Premium Increases

The UK Is Suddenly a Flashpoint in the Battle Over Price and Access

Examining the Latest Launch Price: Ionis’ Dawnzera

European Tariffs — As Expected — Come in at 15%, But the Trade Deal Protects Against Even Bigger Levies

Most Viewed
  • CMS Patient-Focused Listening Session Transcripts (2,456)
  • Working Out the Strange Math and Weird Consequences of IRA Inflation Penalties (1,582)
  • New JAMA Research Shows How Much — and How Rapidly — Part D Plans Have Shifted Drug Costs to Consumers (1,450)
  • Bernie Sanders Wants to Talk to CEOs About US vs ROW Pricing. Bring It On, I Say. (1,373)
  • More IRA Lawsuits Coming, PhRMA Chief Predicts (1,358)
Archives
  • August 2025 (21)
  • July 2025 (21)
  • June 2025 (20)
  • May 2025 (21)
  • April 2025 (21)
  • March 2025 (20)
  • February 2025 (17)
  • January 2025 (21)
  • December 2024 (16)
  • November 2024 (17)
  • October 2024 (19)
  • September 2024 (19)
  • August 2024 (17)
  • July 2024 (18)
  • June 2024 (15)
  • May 2024 (17)
  • April 2024 (21)
  • March 2024 (18)
  • February 2024 (18)
  • January 2024 (18)
  • December 2023 (18)
  • November 2023 (16)
  • October 2023 (21)
  • September 2023 (6)
Cost Curve NewsCost Curve News
  • Home
  • About
  • News
  • Subscribe